Breast Cancer Research

official impact factor 5.79

Download references

Open Access

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

Mark D Pegram*, Virginia F Borges, Nuhad Ibrahim, Jyotsna Fuloria, Charles Shapiro, Susan Perez, Karen Wang, Franziska Schaedli Stark and Nigel Courtenay Luck

Breast Cancer Research 2009, 11:R73 doi:10.1186/bcr2409

Include


Format